Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Expert Opinion on Drug Metabolism & Toxicology
|
October 26, 2010
Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug development
Jaishri Blakeley, Jana Portnow
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 19, 2009
Assessment of pain caused by invasive procedures in cancer patients
Jana Portnow, Christine Lim, Stuart A Grossman
Neuro-Oncology
|
September 14, 2023
NCCN CNS tumor guidelines update for 2023
Burt Nabors, Jana Portnow, Jona Hattangadi-Gluth, et al.
Neuro-Oncology
|
December 18, 2024
NCCN CNS Tumor Guidelines Update for 2024
Louis Burt Nabors, Jona Hattangadi-Gluth, Craig Horbinski, et al.
Neuro-Oncology
|
January 5, 2002
A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas
Jana Portnow, Samia Suleman, Stuart A Grossman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2009
The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation
Jana Portnow, Behnam Badie, Mike Chen, et al.
Journal of Neuro-Oncology
|
March 18, 2014
A pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agent
Jana Portnow, Behnam Badie, Xueli Liu, et al.
Journal of Clinical Medicine
|
January 8, 2025
Single-Cell Transcriptomics Sheds Light on Tumor Evolution: Perspectives from City of Hope's Clinical Trial Teams
Patrick A Cosgrove, Andrea H Bild, Thanh H Dellinger, et al.
Cancer Chemotherapy and Pharmacology
|
October 18, 2024
An intracerebral microdialysis study to determine the neuropharmacokinetics of eribulin in patients with metastatic or primary brain tumors
Zeynep Eroglu, Timothy Synold, Behnam Badie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 6, 2013
A neuropharmacokinetic assessment of bafetinib, a second generation dual BCR-Abl/Lyn tyrosine kinase inhibitor, in patients with recurrent high-grade gliomas
Jana Portnow, Behnam Badie, Susan Markel, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Expert Opinion on Drug Metabolism & Toxicology
|
October 26, 2010
Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug development
Jaishri Blakeley, Jana Portnow
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 19, 2009
Assessment of pain caused by invasive procedures in cancer patients
Jana Portnow, Christine Lim, Stuart A Grossman
Neuro-Oncology
|
September 14, 2023
NCCN CNS tumor guidelines update for 2023
Burt Nabors, Jana Portnow, Jona Hattangadi-Gluth, et al.
Neuro-Oncology
|
December 18, 2024
NCCN CNS Tumor Guidelines Update for 2024
Louis Burt Nabors, Jona Hattangadi-Gluth, Craig Horbinski, et al.
Neuro-Oncology
|
January 5, 2002
A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas
Jana Portnow, Samia Suleman, Stuart A Grossman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2009
The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation
Jana Portnow, Behnam Badie, Mike Chen, et al.
Journal of Neuro-Oncology
|
March 18, 2014
A pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agent
Jana Portnow, Behnam Badie, Xueli Liu, et al.
Journal of Clinical Medicine
|
January 8, 2025
Single-Cell Transcriptomics Sheds Light on Tumor Evolution: Perspectives from City of Hope's Clinical Trial Teams
Patrick A Cosgrove, Andrea H Bild, Thanh H Dellinger, et al.
Cancer Chemotherapy and Pharmacology
|
October 18, 2024
An intracerebral microdialysis study to determine the neuropharmacokinetics of eribulin in patients with metastatic or primary brain tumors
Zeynep Eroglu, Timothy Synold, Behnam Badie, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 6, 2013
A neuropharmacokinetic assessment of bafetinib, a second generation dual BCR-Abl/Lyn tyrosine kinase inhibitor, in patients with recurrent high-grade gliomas
Jana Portnow, Behnam Badie, Susan Markel, et al.
Page
of 5